ENTITY
Laurus Labs

Laurus Labs (LAURUS IN)

65
Analysis
Health Care • India
Laurus Labs Limited researches, develops, manufactures, and sells active pharmaceutical ingredients (APIs) in India and internationally. It offers APIs for anti-retroviral and hepatitis C; and APIs in oncology and other therapeutic areas. .
more
bullish•Aarti Drugs Ltd
•12 Sep 2020 14:27

India Small Caps: Position for Outperformance Vs Large & Mid Caps

Late Friday evening, the Securities and Exchange Board of Indian 

Logo
694 Views
Share
bullish•Laurus Labs
•16 Nov 2018 20:30

Laurus Labs 2QFY19 Results Update - Growth Likely to Begin from FY20E

Laurus Labs (LAURUS IN) disappointed on sales and reported PAT but EBITDA margins (adjusted for one-time costs) were better than our...

Share
bullish•Laurus Labs
•11 Aug 2018 20:21

Laurus Labs - 1QFY19- One More Difficult Quarter Ahead, Strong Growth in FY20E

Laurus Labs reported 1QFY19 results on 3rd August 2018 and held a conference call on 4th August 2018. Revenues grew 9.7% YoY to Rs. 5,390 Mn,...

Share
bullish•Laurus Labs
•22 Jun 2018 20:06

Laurus Labs - Annual Report Review

According to Annual Report FY18, Laurus Labs (LAURUS IN) has strengthened its business with strong R&D, building capacities and expanding...

Share
bullish•Laurus Labs
•14 May 2018 20:29

Laurus Labs- 4QFY18 Result Update

Laurus Labs reported 4QFY18 results on 10th May 2018 and held a conference call on 11th May 2018.Performance Highlights  Laurus reported Q4FY18...

Share
x